Publications by authors named "Jurij Aguiar Zdovc"

Claim this Profile
D
Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease.
Panagiotis-Dimitrios Mingas, Jurij Aguiar Zdovc, Iztok Grabnar, David Drobne, Tomaž Vovk

Pharmaceuticals (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson

Neuropsychopharmacology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of population pharmacokinetic models of gentamicin in paediatric population from preterm newborns to adolescents.
Mateja Črček, Iztok Grabnar, Jurij Aguiar Zdovc, Štefan Grosek, Mojca Kerec Kos

Acta Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors.
Jurij Aguiar Zdovc, Mihaela Vaupotič, Gregor Marolt, Lea Knez, Renata Režonja Kukec

Cancer Chemother Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability enhancement of simvastatin via dry emulsion systems: Comparison of spray drying and fluid bed layering technology.
Mitja Pohlen, Jurij Aguiar Zdovc, Jurij Trontelj, Janez Mravljak, Mirjam Gosenca Matjaž

Eur J Pharm Biopharm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.
Jurij Aguiar Zdovc, Jurij Hanžel, Tina Kurent, Nejc Sever, Matic Koželj

Pharmaceutics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis